subscribeSubscribe
Sandoz must cough up $39M after losing Allergan patent fight

Sandoz must cough up $39M after losing Allergan patent fight
Kevin Dunleavy FIERCE PHARMA
04 Apr 2023
Share Share
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit

Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit
Katherine Lewin ENDPTS
03 Apr 2023
Share Share
Eugia`s Generic Bimatoprost Receives Approval in the U.S.

Eugia`s Generic Bimatoprost Receives Approval in the U.S.
FDA
06 Oct 2022
Share Share
Allergan to Present Data from its Leading Portfolio of Eye Care Treatments

Allergan to Present Data from its Leading Portfolio of Eye Care Treatments
PRNEWSWIRE
24 Feb 2022
Share Share
Micro Labs`s Generic Bimatoprost Receives Approval In US

Micro Labs`s Generic Bimatoprost Receives Approval In US
FDA
19 May 2021
Share Share
FAMAR & Medicom announce the acquisition by Medicom dossier of BIMATOPROST

FAMAR & Medicom announce the acquisition by Medicom dossier of BIMATOPROST
PRESS RELEASE
09 Feb 2021
Share Share
Micro Labs`s Generic Bimatoprost Receives Approval In US

Micro Labs`s Generic Bimatoprost Receives Approval In US
FDA
08 Sep 2020
Share Share
Allergan Receives FDA Approval for DURYSTA

Allergan Receives FDA Approval for DURYSTA
PR NEWSWIRE
05 Mar 2020
Share Share
FDA approves Allergan`s long-term eye implant for glaucoma

FDA approves Allergan`s long-term eye implant for glaucoma
Conor Hale FIERCE BIOTECH
05 Mar 2020
Share Share
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release

Allergan to Present New Data for Investigational Bimatoprost Sustained-Release
PR NEWSWIRE
25 Feb 2020
Share Share